Finance

Lists
NPCE:NASDAQ
Neuropace Inc
$14.28
+0.92%
(+0.13) 1D
Sep 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NPCE...
Open
$14.17
High
$14.56
Low
$14.05
Mkt. cap
490.15M
Avg. vol.
146.30K
Volume
0.00
52-wk high
$19.60
52-wk low
$9.22
EPS
-$0.57
Beta
1.94
Shares outstanding
34.32M
No. of employees
220
Open
$14.17
High
$14.56
Low
$14.05
Mkt. cap
490.15M
Avg. vol.
146.30K
Volume
0.00
52-wk high
$19.60
52-wk low
$9.22
EPS
-$0.57
Beta
1.94
Shares outstanding
34.32M
No. of employees
220
News stories
From web sources and news partners
About Neuropace Inc
CEO-
Employees220
Founded1997
Headquarters-
SectorMedical device
Websiteneuropace.com
Analyst ratings
Based on 7 analysts giving stock ratings to NPCE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for NPCE in the last 3 months.
Highest
Current $14.28
$22.00 (+54.06%)
Average
$20.00 (+40.06%)
Lowest
$18.00 (+26.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brett Fishbin
KeyBanc
Buy
Initiated
$18.00
+26.1%
09/17/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
$21.00
+47.1%
08/17/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$20.00
+40.1%
08/13/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
$20.00
+40.1%
08/12/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
$19.00
+33.1%
08/12/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$20.00
+40.1%
07/29/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$22.00
+54.1%
07/28/2026
Rohin K Patel
J.P. Morgan
Buy
Maintained
$20.00
+40.1%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
27.35M
26.59M
22.07M
22.83M
Cost of goods sold
6.19M
6.01M
4.02M
3.92M
Cost of revenue
6.19M
6.01M
4.02M
3.92M
Research and development expenses
6.58M
7.03M
7.19M
6.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.19M
15.32M
16.43M
17.15M
Operating expense
23.77M
22.34M
23.62M
24.05M
Total operating expenses
29.95M
28.36M
27.64M
27.97M
Operating income
-2.60M
-1.77M
-5.57M
-5.14M
Other non operating income
82.00K
-41.00K
-165.00K
-41.00K
EBT including unusual items
-3.50M
-2.73M
-6.69M
-6.20M
EBT excluding unusual items
-3.50M
-2.77M
-6.69M
-6.20M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.50M
-2.73M
-6.69M
-6.20M
Net profit margin
-12.78%
-10.26%
-30.31%
-27.16%
Earnings per share
-0.11
-0.08
-0.20
-0.18
Interest and investment income
667.00K
638.00K
565.00K
523.00K
Interest expense
-1.64M
-1.60M
-1.52M
-1.54M
Net interest expenses
-978.00K
-962.00K
-956.00K
-1.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.55M
-1.69M
-5.51M
-5.08M
Gain or loss from assets sale
-
12.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps